InterCure Ltd. (TLV:INCR)
Israel
· Delayed Price · Currency is ILS · Price in ILA 554.00
-11.50 (-2.03%)
May 13, 2025, 5:24 PM IDT
InterCure Market Cap
InterCure has a market cap or net worth of 266.71 million as of May 13, 2025. Its market cap has decreased by -35.60% in one year.
Market Cap
266.71M
Enterprise Value
400.16M
Revenue
238.85M
Ranking
n/a
PE Ratio
n/a
Stock Price
554.00
Market Cap Chart
Since December 16, 2010, InterCure's market cap has increased from 6.41M to 266.71M, an increase of 4,061.59%. That is a compound annual growth rate of 29.52%.
Market Cap History
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Teva Pharmaceutical Industries | 68.75B |
| Danel (Adir Yeoshua) | 2.36B |
| Kamada | 1.43B |
| Bait Bakfar | 1.15B |
| Novolog (Pharm-Up 1966) | 794.87M |
| SofWave Medical | 722.24M |
| Ilex Medical | 680.80M |
| BrainsWay | 586.43M |